“Potency evaluation of unfractionated heparins commercialized in Brazil through anti-factor Xa and anti-factor IIa chromogenic tests and coagulation assay: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e01923 | Publicado em: 11/05/2023”, Vigil Sanit Debate, vol. 11, p. 1–10, maio 2023, doi: 10.22239/2317-269x.01923.